PerknElmer’s portfolio provides disease researchers the tools that enable insights and interactions between cell types and organ systems that lead to breakthroughs in prevention, early detection and treatment of diseases.
CNS research seeks to advance treatment for central nervous system disorders through the discovery and quantitation of biomarkers, mechanisms, and drug targets. Our broad range of CNS products meets all the needs of in vitro, in situ, and in vivo central nervous system research.
We offer biomarker detection kits with AlphaLISA® and LANCE® TR-FRET technology, cellular and in vivo imaging systems, and tissue pathology solutions to assess mechanisms of CNS disease in biochemical, cellular, tissue, and animal models. We also provide target-specific radiochemicals, radioligands, and receptor-transfected cell lines and cell membranes.
Applications for our CNS products include:
Our CNS products are also well suited for CNS research in neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s. Gain precise insight on disease biomarkers like phospho-tau, Ab42/Ab40, vimentin, and frataxin, as well as relevant receptors such as dopamine DA1R/DA2R.
Immuno-oncology has emerged as an exciting area of personalized medicine because of its tremendous potential to harness the powerful immune system to target and destroy cancer cells with few side effects, when targeted to the right tumor at the right time. Researchers are exploring the complex relationship between tumor cells and the immune system within the tumor microenvironment in order to discover new immuno-oncology targets and therapies.
Our cancer immunotherapy research solutions span the entire drug discovery workflow, from drug screening to studies in pre-clinical animal models to imaging of human tumor samples in clinical trials.
Cancer is not a single disease, but a complex group of hundreds of separate diseases – and the global incidences of these cancers are increasing all the time. There is an increasing urgency to understand the biology of cancer and translate that information to clinical outcomes to better treat and ultimately eradicate the disease.
We are committed to helping you explore and unravel the complexities of cancer and translate your findings into more effective treatments with a diverse range of solution tools to further your research. Whether you are studying cancer at the genomic level, elucidating cellular pathways, determining a compound’s effects on 3D tumor models, studying tumor growth in animal models, or examining the tumor and its microenvironment. We know that the next big cancer breakthrough will begin with research. And that research begins with you.
For research purposes only. Not for use in diagnostic procedures.
Cardiovascular disease is a leading cause of death globally, and understanding its causes is critical for treatment and preventative care. Our phenotypic and target-based products support your cardiovascular disease detection and research, allowing greater visibility into the mechanisms that cause it.
The study of angiotensin, troponin, adiponectin, apolipoprotein, adrenergic receptors, and factors affecting cardiotoxicity is a major component of cardiovascular disease research, and requires effective detection and imaging as well as the ability to detect key biomarkers.
We offer a broad range of products to help you research cardiovascular disease. Our cardiovascular disease research products allow you to:
Because infectious disease research deals with a wide range of viral, bacterial, and fungal pathogens, it demands analytical instruments that are precise but also versatile. Count on our in vivo, in situ, cellular and biochemical research products for infectious disease detection and biomarker quantitation.
Our products for infectious disease research include:
This product portfolio meets the needs of many applications for infectious disease detection and research:
Inflammation is a natural marker for bodily health, and abnormal inflammatory response is indicated in an increasingly wide net of diseases and disorders, from cardiovascular disease and diabetes to major depression. Detect and quantitate inflammatory biomarkers with our wide range of in vivo, cellular, in situ, and biochemical inflammation research products.
Our products for inflammation research include:
This product portfolio meets the demands of many types of inflammation research:
Metabolic diseases like diabetes are increasingly widespread, and research for this class of diseases relies on discovering and quantifying biomarkers to elucidate underlying mechanisms and uncover novel drug targets. Our portfolio of metabolic assays are well suited for metabolic disease research in vitro, in vivo, and in situ, and offer novel tools for your research workflow from start to finish.
Metabolic diseases are systemic and manifest with a variety of biological changes, from autophagy dysfunction to altered blood coagulation. For easy detection of a wide range of metabolic biomarkers, we offer fast and pre-validated metabolic assay reagents, kits, and imaging systems. For targeted binding studies, we also provide target-specific radiolabeled reagents.
Our products for metabolic disease research include:
The range of tools offered allows for the detection and quantitation of many key biomolecules in metabolic disease research. Gain precise insight on disease biomarkers like c-reactive protein, fibrinogen, IGF, FGF, insulin and glucagon, leptin and ghrelin, adiponectin, and factor VIII.